Phototherapy for neonatal jaundice

New England Journal of Medicine

Volumn 358, Issue 23, 2008, Pages 2523-2524

  Csoma, Zsanett ^a   Kemeny, Lajos ^a   Olah, Judit ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

BLUE LIGHT; CORRELATION ANALYSIS; DNA DAMAGE; DYSPLASTIC NEVUS; HUMAN; IMMUNE SYSTEM; LETTER; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MONOZYGOTIC TWINS; NEWBORN JAUNDICE; NONHUMAN; PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION;

HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; LIGHT; NEVUS, PIGMENTED; PHOTOTHERAPY; TWINS, MONOZYGOTIC; ULTRAVIOLET RAYS;

EID: 44849106386     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Csoma Z, Hencz P, Orvos H, et al. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 2007;119:1036-7.
2. Idem. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 2007;119:1269.
3. Wang SQ, Setlow R, Berwick M, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001;44:837-46.
4. Mahmoud BH, Hexsel CL, Hamzavi IH, Lim HW. Effects of visible light on the skin. Photochem Photobiol 2008;84:450-62.